These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 15268838)
1. [Experimental study of Retinoblastoma inhibition using all trans Retinoic Acid ]. Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):272. PubMed ID: 15268838 [No Abstract] [Full Text] [Related]
2. [Phosphorylated JNK mediated apoptosis induced by all trans retinoid acid in human retinoblastoma cell line]. Min HB; Wang JW; Sun JH; Bu SZ; Huang Q Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):130-3. PubMed ID: 12795836 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration. Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284 [TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295 [TBL] [Abstract][Full Text] [Related]
5. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833 [TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell characteristics in retinoblastoma. Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903 [TBL] [Abstract][Full Text] [Related]
7. Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma. Kase S; Yoshida K; Ohgami K; Shiratori K; Harada T; Ohno S Anticancer Res; 2005; 25(6B):3843-6. PubMed ID: 16309169 [TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma teaches a new lesson. te Riele H Cell; 2007 Oct; 131(2):227-9. PubMed ID: 17956722 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells. Guo J; Xiao B; Lou Y; Yan C; Zhan L; Wang D; Zhao W J Gastroenterol Hepatol; 2006 Feb; 21(2):443-8. PubMed ID: 16509872 [TBL] [Abstract][Full Text] [Related]
10. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells. Chun KH; Lotan R Cell Death Differ; 2006 Oct; 13(10):1830-2. PubMed ID: 16601752 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma. Winter U; Buitrago E; Mena HA; Del Sole MJ; Laurent V; Negrotto S; Francis J; Arana E; Sgroi M; Croxatto JO; Djaballah H; Chantada GL; Abramson D; Schaiquevich P Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4382-93. PubMed ID: 26176875 [TBL] [Abstract][Full Text] [Related]
12. Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma. Zhang H; Rosdahl I Cancer Lett; 2005 Jan; 217(1):33-41. PubMed ID: 15596294 [TBL] [Abstract][Full Text] [Related]
13. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 9-cis retinoic acid for a new remedy of human retinoblastoma. Tsukamoto H; Kurokawa T; Hirata K; Ishibashi S; Mishima HK Biochem Mol Biol Int; 1998 Dec; 46(5):987-91. PubMed ID: 9861453 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of six drug sensitivities in established cell lines of SO-Rb50 and SO-Rb70]. Zhang P; Feng G; Yi Y; Wu Z; Li Y; Zheng J Zhonghua Yan Ke Za Zhi; 1998 Mar; 34(2):109-12. PubMed ID: 11877168 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Dalgard CL; Van Quill KR; O'Brien JM Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379 [TBL] [Abstract][Full Text] [Related]
17. Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro. Zeng Y; Yang Z; Xu JG; Yang MS; Zeng ZX; You C J Clin Neurosci; 2009 Feb; 16(2):285-94. PubMed ID: 19091570 [TBL] [Abstract][Full Text] [Related]
18. Melatonin enhances retinoic acid induction of cone arrestin gene expression in retinoblastoma cells. Li A; Zhu X; Brown B; Craft CM Adv Exp Med Biol; 2003; 533():361-8. PubMed ID: 15180286 [No Abstract] [Full Text] [Related]
19. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. El-Metwally TH; Hussein MR; Abd-El-Ghaffar SKh; Abo-El-Naga MM; Ulrich AB; Pour PM J Clin Pathol; 2006 Jun; 59(6):603-10. PubMed ID: 16473924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]